AHA bulletin highlights Baxter’s efforts to increase access, supply of IV solutions
AHA today Oct. 24 a Special Bulletin with updates from Baxter on its efforts to increase access to and supply of IV solutions in response to the effects of Hurricane Helene on its manufacturing facility in North Carolina. Baxter anticipates restarting the highest-throughput IV solutions manufacturing line at the impacted plant within the next week. In addition, the Food and Drug Administration authorized temporary importation for a variety of products from two additional Baxter plants in Thailand and Singapore, bringing the total number of facilities authorized to import products to seven. See AHA’s Special Bulletin for more updates.
Related News Articles
Headline
President Trump April 9 announced that reciprocal tariffs that went into effect after midnight for certain nations will be paused for 90 days, while tariffs…
Headline
The Food and Drug Administration March 14 released a notice on a nationwide shortage of hemodialysis tubes expected to last through early fall. On Jan. 8, B.…
Headline
The Centers for Disease Control and Prevention Feb. 6 released a report on emergency department use during the Los Angeles County wildfires that began…
Headline
The AHA late Feb. 4 told the administration that its current and proposed tariffs on Canada, Mexico and China may jeopardize the availability of vital…
Perspective
When a man sped his pickup truck down a New Orleans street on New Year’s Day killing 14 people and injuring more than 30, area hospitals and health…
Headline
Baxter Jan. 28 announced that IV solutions production has been restarted on all manufacturing lines at its North Carolina site impacted by Hurricane Helene in…